Amesite (AMST) risk factors, FY2025 10-K

Risks Related to Our Healthcare and AI Solutions Business

1. 01Compliance and Regulatory Risks98% rewritten
2. 02Adoption, Market Penetration, and Growth RisksNew

General and Macroeconomic Risks

1. 03We face significant operational and financial risks
2. 04We face combined legal and reputational risks because of the data we manage and the nature of the business

General Risks

1. 05There is substantial doubt about our ability to continue as a going concern
2. 06We are dependent on the services of certain key management personnel, employees, advisors, and consultants. If we are unable to retain or motivate such individuals or hire qualified personnel, we may not be able to grow effectively
3. 07Our customers will rely on us to deliver stable platforms, with correct measures of performance in a manner that users can easily use
4. 08We have a history of losses, will need substantial additional funding to continue our operations and may not achieve or sustain profitability in the future
5. 09We may engage in future acquisitions that could disrupt our business, cause dilution to our stockholders and harm our financial condition and operating results
6. 10If our security measures or those of our future business partners are breached or fail and result in unauthorized disclosure of data, we could lose customers and/or fail to attract new customers. Such breach or failure could also harm our reputation and expose us to protracted and costly lawsuits
7. 11Unfavorable global economic, business, or political conditions could adversely affect our business, financial condition or results of operations30% rewritten
8. 12Cyber security risks and the failure to maintain the integrity of internal, partner, and consumer data could result in damages to our reputation, the disruption of operations and/or subject us to costs, fines or lawsuits

Risks Related to Our Common Stock

1. 13An active trading market for our common stock may not be sustained
2. 14We may acquire other companies or technologies, which could divert our management’s attention, result in dilution to our stockholders and otherwise disrupt our operations and adversely affect our operating results
3. 15Market and economic conditions may negatively impact our business, financial condition and share price
4. 16Future sales and issuances of our securities could result in additional dilution of the percentage ownership of our shareholders and could cause our share price to fall39% rewritten
5. 17We are an “emerging growth company” and can avail ourselves of reduced disclosure requirements applicable to emerging growth companies, which could make our common stock less attractive to investors
6. 18We may be at risk of securities class action litigation
7. 19The Nasdaq Capital Market may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions69% rewritten
8. 20Financial reporting obligations of being a public company in the United States are expensive and time-consuming, and our management will be required to devote substantial time to compliance matters
9. 21Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval
10. 22Certain provisions of our certificate of incorporation and Delaware law make it more difficult for a third party to acquire us and make a takeover more difficult to complete, even if such a transaction were in stockholders’ interest